Home › Compare › KBBTF vs SBUX

KBBTF vs SBUX: Dividend Comparison 2026

KBBTF yields 208.33% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBBTF wins by $151.33M in total portfolio value
10 years
KBBTF
KBBTF
● Live price
208.33%
Share price
$0.96
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$151.48M
Annual income
$77,914,744.95
Full KBBTF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — KBBTF vs SBUX

📍 KBBTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBBTFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBBTF + SBUX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KBBTF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBBTF
Annual income on $10K today (after 15% tax)
$17,708.33/yr
After 10yr DRIP, annual income (after tax)
$66,227,533.21/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, KBBTF beats the other by $66,171,569.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBBTF + SBUX for your $10,000?

KBBTF: 50%SBUX: 50%
100% SBUX50/50100% KBBTF
Portfolio after 10yr
$75.82M
Annual income
$38,990,292.53/yr
Blended yield
51.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

KBBTF
No analyst data
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBBTF buys
0
SBUX buys
0
No recent congressional trades found for KBBTF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBBTFSBUX
Forward yield208.33% ✓2.75%
Annual dividend / share$2.00$2.46 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3% ✓
Portfolio after 10y$151.48M$157.5K ✓
Annual income after 10y$77,914,744.95 ✓$65,840.13
Total dividends collected$143.08M ✓$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: KBBTF vs SBUX ($10,000, DRIP)

YearKBBTF PortfolioKBBTF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$31,533$20,833.33$11,107$407.21+$20.4K → KBBTF
2$95,137$61,396.68$12,512$626.87+$82.6K → KBBTF
3$274,915$173,118.00$14,366$978.69+$260.5K → KBBTF
4$761,685$467,526.04$16,929$1,557.50+$744.8K → KBBTF
5$2,025,599$1,210,595.57$20,658$2,543.80+$2.00M → KBBTF
6$5,176,190$3,008,799.54$26,406$4,302.22+$5.15M → KBBTF
7$12,724,177$7,185,654.07$35,877$7,622.00+$12.69M → KBBTF
8$30,123,158$16,508,287.86$52,741$14,352.64+$30.07M → KBBTF
9$68,756,679$36,524,900.02$85,676$29,243.03+$68.67M → KBBTF
10$151,484,391$77,914,744.95$157,513$65,840.13+$151.33M → KBBTF

KBBTF vs SBUX: Complete Analysis 2026

KBBTF — Stock

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.

Full KBBTF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this KBBTF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBBTF vs SCHDKBBTF vs JEPIKBBTF vs OKBBTF vs KOKBBTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.